Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, May 2000, p. 1377-1380, Vol. 44, No. 5
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Comparative Killing Rates of Fluoroquinolones
and Cell Wall-Active Agents
Joan C.
Fung-Tomc,*
Elizabeth
Gradelski,
Lourdes
Valera,
Benjamin
Kolek, and
Daniel P.
Bonner
Department of Microbiology, Bristol-Myers
Squibb Company, Wallingford, Connecticut 06492
Received 8 October 1999/Returned for modification 24 November
1999/Accepted 11 February 2000
Killing rates of fluoroquinolones,
-lactams, and vancomycin were
compared against Enterobacteriaceae, Staphylococcus
aureus, pneumococci, streptococci, and Enterococcus
faecalis. The times required for fluoroquinolones to decrease
viability by 3 log10 were 1.5 h for
Enterobacteriaceae, 4 to 6 h for staphylococci, and
6 h for streptococci and enterococci. Thus, the rate of killing by
fluoroquinolones is organism group dependent; overall, they killed more
rapidly than
-lactams and vancomycin.
*
Corresponding author. Mailing address: Bristol-Myers
Squibb Company, Department of Microbiology-104, 5 Research Pkwy.,
Wallingford, CT 06492. Phone: (203) 677-6370. Fax: (203) 677-6771. E-mail: fungtomj{at}bms.com.
Antimicrobial Agents and Chemotherapy, May 2000, p. 1377-1380, Vol. 44, No. 5
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wiuff, C., Andersson, D. I.
(2007). Antibiotic treatment in vitro of phenotypically tolerant bacterial populations. J Antimicrob Chemother
59: 254-263
[Abstract]
[Full Text]
-
Chung, P., McNamara, P. J., Campion, J. J., Evans, M. E.
(2006). Mechanism-Based Pharmacodynamic Models of Fluoroquinolone Resistance in Staphylococcus aureus.. Antimicrob. Agents Chemother.
50: 2957-2965
[Abstract]
[Full Text]
-
Wiuff, C., Zappala, R. M., Regoes, R. R., Garner, K. N., Baquero, F., Levin, B. R.
(2005). Phenotypic Tolerance: Antibiotic Enrichment of Noninherited Resistance in Bacterial Populations. Antimicrob. Agents Chemother.
49: 1483-1494
[Abstract]
[Full Text]
-
Regoes, R. R., Wiuff, C., Zappala, R. M., Garner, K. N., Baquero, F., Levin, B. R.
(2004). Pharmacodynamic Functions: a Multiparameter Approach to the Design of Antibiotic Treatment Regimens. Antimicrob. Agents Chemother.
48: 3670-3676
[Abstract]
[Full Text]
-
Gradelski, E., Kolek, B., Bonner, D., Fung-Tomc, J.
(2002). Bactericidal mechanism of gatifloxacin compared with other quinolones. J Antimicrob Chemother
49: 185-188
[Abstract]
[Full Text]
-
Gradelski, E., Valera, L., Bonner, D., Fung-Tomc, J.
(2001). Synergistic Activities of Gatifloxacin in Combination with Other Antimicrobial Agents against Pseudomonas aeruginosa and Related Species. Antimicrob. Agents Chemother.
45: 3220-3222
[Abstract]
[Full Text]
-
Venezia, R. A., Domaracki, B. E., Evans, A. M., Preston, K. E., Graffunder, E. M.
(2001). Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure. J Antimicrob Chemother
48: 375-381
[Abstract]
[Full Text]